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Abstract
Background: The objective of this study was to translate and to test the reliability and validity of
the 10-item Dermatology Life Quality Index (DLQI) questionnaire in Iranian patients with vitiligo.
Methods:  Using a standard "forward-backward" translation procedure, the English language
version of the questionnaire was translated into Persian (the Iranian official language) by two
bilinguals. Seventy patients with vitiligo attending the Department of Dermatology, Saadi Hospital,
Shiraz, Iran, were enrolled in this study.
The reliability and internal consistency of the questionnaire were assessed by Cronbach's alpha
coefficient and Spearman's correlation, respectively. Validity was performed using convergent
validity.
Results: In all, seventy people entered into the study. The mean age of respondents was 28.3 (SD
= 11.09) years. Scores on the DLQI ranged from 0 to 24 (mean ± SD, 7.05 ± 5.13). Reliability
analysis showed satisfactory result (Cronbach's α coefficient = 0.77). There were no statistically
significant differences between daily activity (DA) and personal relationship (PR) scale mean scores
in generalized versus focal-segmental involvement in sufferers (P = 0.056, P = 0.053, respectively).
There were also strong differences between the mean scores of the PR (personal relationship)
scale with the involvement of covered only and covered/uncovered areas (P= 0.016) that was
statistically significant in the second group.
Conclusions: The study findings showed that the Persian version of the DLQI questionnaire has
a good structural characteristic and is a reliable and valid instrument that can be used for measuring
the effects of vitiligo on quality of life.
Background
Vitiligo is an important skin disease having major impact
on the quality of life of patients suffering from vitiligo.
Appearance of skin can condition an individual self-
image, and any pathological alteration can have psycho-
logical consequences [1,2]. Many vitiligo patients feel dis-
tressed and stigmatized by their condition. These patients
often develop negative feeling about it, which are
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reinforced by their experiences over a number of years.
Most patients of vitiligo report feelings of embarrassment,
which can lead to a low self-esteem and social isolation
[3]. The Dermatology Life Quality Index questionnaire is
designed for use in adults, i.e. patients over the 16. It is
self-explanatory and can be simply handed to the patient
who is asked to fill it in without the need for detailed
explanation. It is usually completed in one to two min-
utes. The questions were classified to 6 headings items:
symptoms and feelings (questions 1 and 2), daily activi-
ties (questions 3 and 4), leisure (questions 5 and 6), and
personal relationships (questions 8 and 9) each item with
maximum score 6; work and school (question 7), and
treatment (question10) each item with maximum score 3
[4].
The DLQI is calculated by summing the score of each
question resulting in a maximum of 30 and a minimum
of 0. The higher the score, the more quality of life is
impaired. The DLQI can also be expressed as a percentage
of the maximum possible score of 30.
The scores for each of these sections can also be expressed
as a percentage of either 6 or 3.
Since the DLQI is a brief, simple, easy to complete, and its
application in research settings as a screening tool is well
documented, it was decided to translate the DLQI into
Persian (the Iranian official language) and to examine
reliability and validity of this questionnaire in an Iranian
population with vitiligo.
Methods
The standard "forward-backward" procedure was applied
to translate the questionnaire from English into Persian.
Two independent bilinguals translated the items and two
others translated the response categories and after cultural
adaptation, a provisional version was provided. Subse-
quently, it was back translated into English and then the
final version was provided. The cultural adaptation was
done by the translation of the "partner" to the "spouse" in
Persian language and adding of it in question 8 and 9,
respectively.
The final draft of the Persian version was administered to
a sample of patients with vitiligo that referred to Depart-
ment of Dermatology, Saadi Hospital, Shiraz, Iran. There
were no restrictions on patient selection with regard to
extension of lesions. The patients were introduced to the
subject of this study and informed about the personal
nature of the questionnaire, and all those who gave con-
sent were given the DLQI questionnaire to complete. The
questionnaires were completed by the patients whom
were referred to our clinic for psoralen and UVA (PUVA)
therapy. The patients were categorized by extension of
lesions into covered only (vitiligo patches are covered by
cloths) and covered/uncovered involvement and by sever-
ity of disease to focal-segmental (focal is defined as a sin-
gle or a few depigmented macules that are located in a
discrete area, segmental is the unilateral localization of
one or more macules to one area of the body) [5], which
in this study were settled in one category, and generalized
involvement groups (widespread distribution of numer-
ous macules over the integument in a random pattern)
[6]. Age of patients, marital status and the number of
treatment sessions were recorded. Responses on the DLQI
were scored according to the guidelines of Finlay and
Khan [4]. All statistical analyses were carried out using the
Statistical Package for the Social Sciences (SPSS 11.0 for
Windows). To test the reliability, the internal consistency
of the questionnaire was assessed by Cronbach's alpha
coefficient and alpha equal to or greater than 0.70 was
considered satisfactory [7].
Validity was performed using convergent validity to dem-
onstrate the extent to which the DLQI correlated with glo-
bal quality of life. Construct validity was checked by factor
analysis.
Results
Seventy patients aged 18 to 68 (mean ± SD, 28.3 ± 11.09)
years completed the questionnaire. We did not have any
incomplete questionnaires; therefore we included all
questionnaires in our study.
Scores on the DLQI ranged from 0 to 24(mean ± SD, 7.05
± 5.13). The reliability of the questionnaire was obtained
by Cronbach's alpha coefficient (α = 0.77). There were no
statistically significant differences between the sex, item
scores and mean DLQI score. Table 1 shows the results of
item convergent validity tests. The scaling success rates
were 100% for convergent validity of each scale.
Cronbach's α coefficient by gender, marital status, sever-
ity, and extension of disease are shown in Table 2.
There were no statistically significant differences between
item and mean DLQI scores of males versus females and
married versus single cases.
Cronbach's α reliability coefficients ranged from 0.69 to
0.78 for symptoms and feelings (SF) scale, 0.71 to 0.78 for
daily activities (DA) scale, 0.67 to 0.88 for leisure (L)
scale, and 0.50 to 0.99 for personal relationships (PR)
scale. The reliability coefficient for work and school (WS)
scale was equal to treatment (T) scale that was 0.100.
Table 2 shows comparison of Cronbach's α in each scale
separately. The DA scale was found to have a strong asso-
ciation with gender (female scores were greater than male
ones).BMC Dermatology 2004, 4:8 http://www.biomedcentral.com/1471-5945/4/8
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The L scale was found to have significant relationship with
the severity of the disease (generalized versus focal/seg-
mental) (P value = 0.018).
The DA and PR scales, also had no statistical association
with severity factor (P = 0.056 and P = 0.053,
respectively).
The PR scale had strong correlation with the type of the
extension of lesions (covered only versus covered/uncov-
ered type) (P value = 0.016).
There was no association between the numbers of treat-
ment sessions with the type of disease (generalized versus
focal/segmental).
The number of treatment sessions and mean DLQI score
was found to have a positive correlation coefficient (P
value = 0.02, r = 0.28) but this correlation was statistically
significant in the generalized type only (P value = 0.008, r
= 0.37).
Spearman's correlation coefficient of severity of the dis-
ease with questions 5, 6, and 8 were 0.25, 0.24, and 0.26
respectively. For question 8 and the extension of disease
and also for question 1 and the stage of disease it was
equal to 0.26.
The result in question 4 and gender status was statistically
significant (0.008) there was no statistically significance
correlation between the age and each of questions.
The result of question 9 and marital status was statistically
significant (P = 0.002) and it was higher in married
patients. The range of the paired correlations between the
items was 0.17–0.68.
Table 1: Item scaling tests: convergent validity for DLQI scales




Scaling Success1 Scaling Success Rate2 Internal consistency 
(Cronbach's α)
SF 2 0.69–0.78 2/2 100 0.70
DA 2 0.71–0.78 2/2 100 0.76
L 2 0.67–0.88 2/2 100 0.71
WS 1 1.00 1/1 100 1.00
PR 2 0.50–0.99 2/2 100 0.79
T 1 1.00 1/1 100 1.00
SF (Symptoms and feelings), DA (Daily activities), L (Leisure), WS (Work and School),PR (Personal relationships), T (Treatment) 1- 
Number of correlation between items and hypothesized scale corrected for overlap ≥ 0.4/ total number of convergent validity tests. 2- Scaling 
success rate is the previous column as a percentage.
Table 2: Cronbach's coefficient by gender, marital status, severity, and extension of disease













1 The number of patients in each category.BMC Dermatology 2004, 4:8 http://www.biomedcentral.com/1471-5945/4/8
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Factor analysis is performed to determine the Persian ver-
sion is a two-dimensional measure including social and
psychological parameters (Table 3).
Discussion
The DLQI questionnaire is a well-known instrument for
measuring dermatological distress and has been trans-
lated into a variety of languages [8,9] and [10].
The translation process set by the international quality of
life assessment (IQOLA) project was built on lessons from
cross-cultural psychology and other health survey projects
to develop protocols for translating, validating, and nor-
ming health status questionnaires, entails forward transla-
tion by at least two translators who were native speakers
of the target language, rating of translation equality by
two other bilinguals, and back translation by two transla-
tors who were native speakers of American-English or Brit-
ish-English [11]. Because native English speakers were
unavailable, we did not fully adhere to this strategy. Two
independent Iranian health professionals translated the
items and subsequently, it was back translated into Eng-
lish by two others and then the final version was
provided.
Vitiligo is an acquired depigmentation disorder of great
cosmetic importance affecting 1–4% of the world's popu-
lation. The disease has a major impact on quality of life of
patients, many of whom feel stigmatized by their condi-
tion [12].
Porter et al. studied the effect of vitiligo on sexual relation-
ships and found that embarrassment during sexual rela-
tionships was especially frequent for men with vitiligo
[13]. Salzer and Schallreuter reported that 75% found
their disfigurement moderately or severely intolerable
[14].
Weiss et al compared the difficulties faced by patients with
vitiligo with those with leprosy in India [15]. There may
be a relationship between stress and the development of
vitiligo. Al-Abadie et al. indicated that psychological stress
increases levels of neuroendocrine hormones, affects the
immune system and alters the level of neuropeptides,
which may be the initial steps in pathogenesis of vitiligo
[16].
In general, the finding of this study indicated that mental
health in vitiligo patients is poor and it is strongly associ-
ated with their quality of life. Since the patients with
higher DLQI scores responded less favorably to a given
therapeutic modality [12], improving quality of life in this
group becomes very important task.Severity (generalized
versus focal/segmental) and extension of lesions on cov-
ered only or covered/uncovered areas has an effect on
quality of life of patients. 
This study reports data from a validation study of the 10-
item DLQI questionnaire in Iran. In general the findings
showed promising results and were comparable with
other research finding throughout the world [12]. The
two-dimensional Persian version of DLQI questionnaire
assessed the social and psychological difficulties as other
studies [12]. There was no relationship of DLQI score with
gender, which is consistent with the study of Parsad et al.
[12].
The mean DLQI score in this study was 7.05 that is lower
than that obtained by Finlay and Khan (mean 7.3) [4] and
Parsad et al. (mean 10.67) [12], and it is higher than Kent
and Al-Abadie's study (mean 4.82) [17].
Reliability was associated by internal consistency of the
questionnaire reporting Cronbach's alpha coefficient and
validity was examined by convergent validity showed sat-
Table 3: Factor loadings (rotated) 1 of two-factor solution
DLQI items Social factor Psychological factor
Q 1 .086 .485
Q 2 .545 .305
Q 3 .535 .374
Q 4 .470 .285
Q 5 .564 .473
Q 6 .190 .468
Q 7 .088 .619
Q 8 .813 .186
Q 9 .681 -.195
Q 10 .099 .500
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isfactory results (α = 0.77). Cronbach's α was < 0.7 for
males, focal/segmental, and covered vitiligo that may be
related to small sample size and cultural differences.
The Persian version of the DLQI questionnaire proved to
be acceptable to patients and it is worth nothing that occa-
sionally the questionnaire was administered by a trained
nurse in face-to-face interviews. However this was done in
illiterate patients and some ones indicated that some
questions were difficult to answer, especially question 8.
Perhaps this was the reason why a weaker correlation was
found for this item with its corresponding subscale.
Conclusions
The study finding showed that the Persian version of the
DLQI questionnaire has a good structured characteristic
and is a reliable and valid instrument that can be used for
measuring the effects of the vitiligo on quality of life.
Especially, the reliability of this questionnaire was high in
females and patients with generalized involvement,




DLQI: Dermatology Life Quality Index
SD: standard deviation
IQOLA: international quality of life assessment
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